Acute Myeloid Leukemia PDX Models

Most commercially available blood cancer patient-derived xenograft (PDX) models are transient in nature, and non-transferable through passages (not renewable), without disease symptoms or mortality. However, CrownBio’s PDX models for blood cancer are permanent, and allow the study of disease recurrence after initial treatment challenge and the efficacy testing of novel agents against drug resistance. The CrownBio acute myeloid leukemia (AML) PDX collection consists of several models, including models with patient-relevant mutations e.g. FLT3(+), IDH2 mutation. More

MODEL CANCER TYPE SUBTYPE models per page
AM5512Acute Myeloid LeukemiaM7?VIEW MODEL
AM7577Acute Myeloid LeukemiaM5VIEW MODEL